Dr. Yair Schindel, aMoon Managing Partner, on Covid-19 and Investing in Medtech

Dr. Yair Schindel

When VC aMoon was established in 2017, “the premise was to invest heavily in the convergence of technology and biology, healthcare and data,” says Dr. Yair Schindel, its Managing Partner. Schindel and Marius Nacht, the other founder of the Israeli venture capital firm which has raised to date more than $1 billion, were talking to potential investors about “the coming tsunami of healthtech” over the next 10 years. “Now we see things happening that we only expected to see three or five years from now,” says Schindel. “In that sense, Covid put everything on steroids.”

Read more here

About GilPress

I'm Managing Partner at gPress, a marketing, publishing, research and education consultancy. Also a Senior Contributor forbes.com/sites/gilpress/. Previously, I held senior marketing and research management positions at NORC, DEC and EMC. Most recently, I was Senior Director, Thought Leadership Marketing at EMC, where I launched the Big Data conversation with the “How Much Information?” study (2000 with UC Berkeley) and the Digital Universe study (2007 with IDC). Twitter: @GilPress
This entry was posted in Misc. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *